Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.

Fibroblast growth factor receptor 3 (FGFR3) is expressed in squamous cell carcinoma of the head and neck (SCCHN) including oropharyngeal squamous cell carcinoma (OPSCC) and is a potential therapeutic target. However, information on its correlation with other relevant cancer related proteins stratifi...

Full description

Bibliographic Details
Main Authors: Sreenivas Nannapaneni, Christopher C Griffith, Kelly R Magliocca, Wanqi Chen, Xueying Lyu, Zhengjia Chen, Dongsheng Wang, Xu Wang, Dong M Shin, Zhuo G Chen, Nabil F Saba
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0247498